Anti-Fracture Efficacy of Risedronic Acid in Men.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 349, doi. 10.2165/00044011-200929050-00007
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2009 AND VI 29 AND IP 5
Results: 7
1
2
Pharmacokinetics of Two 6-Day Frovatriptan Dosing Regimens Used for the Short-Term Prevention of Menstrual Migraine.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 325, doi. 10.2165/00044011-200929050-00005
- By:
- Publication type:
- Article
3
Effect of Ivabradine, a Novel Antianginal Agent, on Driving Performance.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 339, doi. 10.2165/00044011-200929050-00006
- By:
- Publication type:
- Article
4
Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 317, doi. 10.2165/00044011-200929050-00004
- By:
- Publication type:
- Article
5
Diary and Patient-Reported Outcomes in Patients with Severe Overactive Bladder Switching from Tolterodine Extended Release 4mg/day to Solifenacin Treatment.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 305, doi. 10.2165/00044011-200929050-00003
- By:
- Publication type:
- Article
6
Combination Therapy with Candesartan Cilexetil 32 mg and Hydrochlorothiazide 25 mg Provides the Full Additive Antihypertensive Effect of the Components.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 293, doi. 10.2165/00044011-200929050-00002
- By:
- Publication type:
- Article
7
HairMax LaserComb Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 5, p. 283, doi. 10.2165/00044011-200929050-00001
- By:
- Publication type:
- Article